Navigating an Increasingly Complex Framework to Improve Patient Outcomes With ICI-Based Therapy

Download All
Review multidisciplinary best practices for safely and effectively incorporating immunotherapies into the management of diverse cancers with downloadable slides, a Webcast, expert commentaries, and microlearning opportunities. Then, get individualized recommendations adapted from NCCN Guidelines® for managing immune-related adverse events with a decision support tool.
Marianne Davies, DNP, CNS, ACNP-BC, AOCNP
John L. Marshall, MD
Sandip P. Patel, MD
Jeffrey S. Weber, MD, PhD
person default
Matthew Zibelman, MD

MedicalMinute Series

Watch this short presentation to gain multidisciplinary expert insights on important safety and efficacy considerations when caring for patients starting immune checkpoint inhibitors.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 23, 2021 Expired: March 22, 2022

Watch this focused video to review fundamentals of immune-related adverse events, and then learn how a medical oncologist manages the most common events including dermatitis, colitis/diarrhea, hepatitis, endocrinopathies, and pneumonitis.

Jeffrey S. Weber, MD, PhD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 23, 2021 Expired: March 22, 2022

Watch this short video to hear how a medical oncologist manages less common immune-related adverse events affecting the neurologic, cardiac, and other systems, and then review expert answers to common clinical questions about optimal toxicity management.

Jeffrey S. Weber, MD, PhD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 23, 2021 Expired: March 22, 2022

Watch this cutting-edge presentation for emerging data and guidance on COVID-19 vaccination for patients with cancer who are receiving immune checkpoint inhibitors.

person default Matthew Zibelman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 24, 2021 Expired: May 23, 2022

Downloadable Slidesets

Download these slides for an expert survey of key safety and efficacy considerations for multidisciplinary healthcare providers caring for patients starting immune checkpoint inhibitors.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Released: March 23, 2021

Download these slides to review fundamentals of immune-related adverse events, and then learn how an expert manages the most common events including dermatitis, colitis/diarrhea, hepatitis, endocrinopathies, and pneumonitis.

Jeffrey S. Weber, MD, PhD Released: March 23, 2021

Download these slides to learn how an expert manages less common immune-related adverse events including neurologic, cardiac, and more, and then review expert answers to common questions about optimal toxicity management.

Jeffrey S. Weber, MD, PhD Released: March 23, 2021

Download these slides for expert insights on key biologic principles, current indications, and clinically relevant biomarkers for immune checkpoint inhibitors.

Sandip P. Patel, MD Released: April 16, 2021

Download these slides for a multidisciplinary overview of strategies for monitoring, evaluating, and managing immune-related adverse events associated with immune checkpoint inhibitors.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Released: April 16, 2021

Download this short summary slideset of key takeaways from a live CCO Webinar featuring expert insights on current indications, clinically relevant biomarkers, and multidisciplinary management strategies for immune-related adverse events associated with immune checkpoint inhibitors.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Sandip P. Patel, MD Released: April 27, 2021

On-Demand Webcast

In this interactive recording of a live CCO webinar, multidisciplinary experts discuss the latest data on safely and effectively leveraging immune checkpoint inhibitors for treating patients with diverse cancers.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Sandip P. Patel, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: May 21, 2021 Expired: May 20, 2022

ClinicalThought

Gain new insights on how to leverage tumor mutational burden to select patients most likely to benefit from ICI-based therapy and on ongoing challenges to optimize management of immune-related adverse events.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP John L. Marshall, MD Released: November 30, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue